Close

Add impact to your LinkedIn

Keep up with the latest updates, insights, and opportunities driving meaningful change in 
the healthcare industries

Follow us

Link

ARCHIMED HEALTHCARE IT acquires 3verest, a private sovereign cloud provider for medical imaging.

3verest hosts and protects the imaging data that radiology departments rely on for diagnosis, under the laws of the country that data belongs to, and is expanding into cardiology and pathology.

 

The HEALTHCARE IT team of global private equity healthcare specialist ARCHIMED is partnering with 3verest, acquiring a majority stake in the company. Its founder and CEO, Scott Crawford, who built the business from the ground up without outside capital, remains a significant shareholder and continues to lead the company.

Founded in 2016 and headquartered in London, with offices in Sydney, Chicago and Munich, 3verest is a healthcare-dedicated private, sovereign cloud infrastructure provider. It owns and operates its own infrastructure rather than reselling capacity from a global hyperscaler, so that the data it holds sits not only in the region a provider chooses but under that region’s legal jurisdiction. It hosts and secures the medical imaging data that clinicians use every day, particularly in radiology. Its infrastructure supports healthcare institutions in the EU, the UK, US, Canada, and in the Asia-Pacific, where performance, interoperability, and data protection are critical to diagnosis. The company works closely with leading Picture Archiving and Communication System (PACS) vendors and holds a multi-jurisdiction certification stack, including a Systems and Organization Controls 2 (SOC 2) audit attestation of its security controls.  “On a hyperscaler you choose a region and hope,” says ARCHIMED Partner Anthony Farias. “The capacity is pooled, the replicas move, and the parent company still answers to a foreign court. On 3verest you can name the datacenter, the operating entity, and the jurisdiction and that doesn’t shift.”

Medical imaging creates one of the most demanding workloads in healthcare. A single hospital archive runs to petabytes (one petabyte equals some 500 billion pages of standard printed text) and grows every year; studies must be retained for decades and returned to a radiologist in seconds, and a migration cannot interrupt a clinical service that never stops. Imaging is growing in volume, size, and complexity, while healthcare providers are moving sensitive patient data to private, sovereign cloud environments with enhanced security. By keeping imaging data instantly available, secure, and compliant in complex regulatory and security environments, 3verest contributes to faster, more reliable diagnoses for patients.

ARCHIMED’s HEALTHCARE IT team targeted care-provider software and infrastructure as a priority investment area through MedSeg, ARCHIMED’s proprietary sector analysis tool covering 500+ sub-segments of the health industry. 3verest was identified as a sector leader through MedDiscover, a proprietary set of tools and processes permitting ARCHIMED to identify and effectively engage with leading companies.

ARCHIMED purchased its majority stake in 3verest through the MED III fund, which closed on €650 million in 2021. MED III and all ARCHIMED funds that are significantly invested (those closed in 2022 or before) are at least top quartile buyout performers for their vintages, according to Preqin data (2026).

Past performance is not a guarantee of future results. Capital at risk. For professional investors only.

 

Who
We are

ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.

160+

professionals,

⅓ Finance, ⅓ Scientists, ⅓ Operational.

ARCHIMED was founded by healthcare professionals who shared the same passion of making a true impact in the healthcare industries. Watch the video to discover the story of ARCHIMED.

Play
0.00
Volume

WHAT
WE DO

We fund, support and scale companies whose activities contribute to improve health outcomes at all levels.

Stago

ExcellGene

Stragen

Esperion Therapeutics

Direct Healthcare Group

Clean Biologics

c. 20%

average annual topline growth
of ARCHIMED companies.

Discover why former CEOs choose ARCHIMED as their strategic partner in our ‘Coffee Chat with a Former CEO’ video. Join us for an authentic conversation, where real experiences and insights come to life.

HOW
WE DO IT

We join forces with scientists, healthcare professionals, entrepreneurs and investors through our 3 main activities:

FUND

We fund healthcare industries globally.

Our latest acquisitions :

Genetica

SUPPORT

We support healthcare entrepreneurs in their companies’ development.

Our latest exit :

AMETRIS

RETURN

We deliver superior returns to our investors and to society.

Our latest acquisitions :

Clubhouse

FUND

We fund healthcare industries globally.

Our latest project:

Genetica

SUPPORT

We support healthcare entrepreneurs in their companies’ development.

Our latest project:

AMETRIS

RETURN

We deliver superior returns to our investors and to society.

Our latest project:

Clubhouse

LATEST
NEWS

October 19, 2026

ARCHIMED HEALTHCARE IT acquires 3verest, a private sovereign cloud provider for medical imaging.

3verest hosts and protects the imaging data that radiology departments rely on for diagnosis, under the laws of the country that data belongs to, and is expanding into cardiology and pathology.

October 14, 2026

ARCHIMED Animal & Environmental Health announces partnership with Genetica Bioscience.

Genetica is a leading expert in bio-based industrial wastewater treatment, and has growing operations in the fast-growing areas of biogas generation and bio-based crop protection.

September 9, 2026

ARCHIMED closes MED IV fund at €1.5 billion hard cap, three times oversubscribed.

MED IV follows the €650 million ($750 million) MED III fund. It will pursue the series’ smallcap healthcare buyout strategy, while building a more diversified, global portfolio.